PDZK1 and central nervous system cancer: When the expression of PDZK1 was suppressed in glioma cells, the percentage of U251 cells in the G0/G1 phase increased from 58% to 66%, whereas the percentage of cells in the S phase decreased from 33% to 25% (Figure 6A, 6B).